MedTrace Logo

Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis

NCT05633706 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-04-15

No results posted yet for this study

Summary

The SIMBA Capsule is a small, single-use, ingestible capsule that allows for the non-invasive sampling of small bowel contents using purely mechanical means. The study will compare the microbial and metabolomics analysis from the sample collected with the capsule series, to same-participant symptom questionnaires and stool microbial analysis.

Conditions

Interventions

DEVICE

fluid biopsy capsule

Collection of a fluid biopsy from the small intestine via ingestible capsule

Sponsors & Collaborators

  • Mitacs

    collaborator INDUSTRY

  • University of Calgary

    collaborator OTHER

  • Nimble Science Ltd.

    lead INDUSTRY

Principal Investigators

  • Chris Andrews, MD · Nimble Science Ltd.

  • Matthew Woo, MD · Nimble Science Ltd.

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-09
Primary Completion
2025-06-06
Completion
2025-06-06

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05633706 on ClinicalTrials.gov